Réaction #795566

ord-586c6044d6fe4607a2776eead51c5c07

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    Lavagewashed with water, brine
  2. 2
    Séchagedried over Na2SO4
  3. 3
    Concentrationconcentrated in vacuo
  4. 4
    AutreThe crude residue was purified via silica gel chromatography (EtOAc-Heptane, 0-90%)

Mode opératoire

To a solution of (Z)-2-((1-((benzhydryloxy)carbonyl)cyclopropoxy)imino)-2-(2-((tert-butoxycarbonyl)amino)thiazol-4-yl)acetic acid (prepared according to Yamawaki et al. Bioorg. Med. Chem. Lett. 2007, 15, 6716-6732) (1.50 g, 2.79 mmol) in DCM (15 mL) at 0° C. was added DIPEA (1.22 mL, 6.98 mmol) and HATU (1.11 g, 2.93 mmol). After warming to rt, a solution of tert-butyl ((2-(((2R,3S)-3-amino-4-oxoazetidin-2-yl)methyl)-2H-1,2,3-triazol-4-yl)methyl)carbamate (827 mg, 2.79 mmol) in DCM:DMF (1.7:1, 12.7 mL). After 1 h of stirring it was diluted with DCM and washed with water, brine, dried over Na2SO4 and concentrated in vacuo. The crude residue was purified via silica gel chromatography (EtOAc-Heptane, 0-90%), to afford the title compound (1.92 g, 84%) as a purple oil. LCMS: Rt=1.08 min, m/z=816.5 (M+1) Method 2m_acidic.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US09174978B2uspto-grants-2015_11